Showing results (431-440 of 1,014) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|June 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, et al.
Cancer Research Communications|June 25, 2024
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell CarcinomaSun M Lim, Seong-San Kang, Dong K Kim, et al.
Cancer Research Communications|June 17, 2024
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in MelanomaHirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, et al.
Cancer Research Communications|June 17, 2024
Characterization of Non-Monotonic Relationships between Tumor Mutational Burden and Clinical OutcomesJordan Anaya, Julia Kung, Alexander S Baras
Cancer Research Communications|June 19, 2024
KRAS Promotes GLI2-Dependent Transcription during Pancreatic CarcinogenesisAshley N Sigafoos, Ezequiel J Tolosa, Ryan M Carr, et al.
Cancer Research Communications|May 15, 2024
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort EvaluationLaura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, et al.
Cancer Research Communications|December 19, 2025
Combining brigatinib with mTOR inhibition to effectively treat NF2-SWN-associated and sporadic NF2-deficient meningiomasLong-Sheng Chang, Janet L Oblinger, Lai Man Natalie Wu, et al.
Cancer Research Communications|November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid TumorsBenjamin T Cooper, Wade T Iams, David B Page, et al.
Cancer Research Communications|December 3, 2025
Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric CancerGuanghui Liu, Xin Tan, Kaibiao Xu, et al.
Cancer Research Communications|December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
Pageof 102